Cholinergic channel modulators as a novel therapeutic strategy for Alzheimer's disease

Expert Opinion on Investigational Drugs

Volumn 5, Issue 1, 1996, Pages 79-100

  Arneric, S P ^a   Holladay, M W ^a   Sullivan, J P ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Cholinergic channel modulator; Neuronal nicotinic acetylcholine receptors; Nicotine; Structure activity relationships

Indexed keywords

3 (2 AZETIDINYLMETHOXY)PYRIDINE; 3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; 3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; A 84543; ACETYLCHOLINE; ALPHA BUNGAROTOXIN; ANABASEINE; ANATOXIN A; ARECOLONE; CHLORPROMAZINE; CYTISINE; DIHYDRO BETA ERYTHROIDINE; DIZOCILPINE; EPIBATIDINE; GALANTAMINE; ION CHANNEL; ION TRANSPORT AFFECTING AGENT; ISOARECOLONE; ISOXAZOLE DERIVATIVE; METANICOTINE; METHYLCARBACHOL; METHYLLYCACONITINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NIMODIPINE; PHYSOSTIGMINE; PROGESTERONE; PYRIDINE DERIVATIVE; RADIOLIGAND; RECEPTOR SUBTYPE; S 1663; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALZHEIMER DISEASE; ANIMAL MODEL; ATTENTION; CHOLINERGIC TRANSMISSION; CLINICAL TRIAL; COGNITION; DEGENERATIVE DISEASE; DRUG SELECTIVITY; HUMAN; LIGAND BINDING; MOLECULAR BIOLOGY; NERVE CELL DEGENERATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PATENT; REVIEW; SMOKING; STRUCTURE ACTIVITY RELATION; TRANQUILIZING ACTIVITY;

EID: 0030047768     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.5.1.79     Document Type: Review

References (0)